Bedel Financial Consulting’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-441
| Closed | -$57K | – | 492 |
|
2022
Q1 | $57K | Hold |
441
| – | – | 0.02% | 367 |
|
2021
Q4 | $67K | Hold |
441
| – | – | 0.02% | 342 |
|
2021
Q3 | $71K | Hold |
441
| – | – | 0.02% | 329 |
|
2021
Q2 | $72K | Hold |
441
| – | – | 0.03% | 325 |
|
2021
Q1 | $66K | Hold |
441
| – | – | 0.03% | 330 |
|
2020
Q4 | $67K | Hold |
441
| – | – | 0.03% | 276 |
|
2020
Q3 | $60K | Sell |
441
-300
| -40% | -$40.8K | 0.03% | 280 |
|
2020
Q2 | $101K | Hold |
741
| – | – | 0.05% | 199 |
|
2020
Q1 | $80K | Hold |
741
| – | – | 0.05% | 208 |
|
2019
Q4 | $89K | Hold |
741
| – | – | 0.05% | 224 |
|
2019
Q3 | $74K | Hold |
741
| – | – | 0.04% | 237 |
|
2019
Q2 | $81K | Hold |
741
| – | – | 0.05% | 223 |
|
2019
Q1 | $83K | Hold |
741
| – | – | 0.05% | 208 |
|
2018
Q4 | $71K | Hold |
741
| – | – | 0.05% | 213 |
|
2018
Q3 | $85K | Hold |
741
| – | – | 0.06% | 209 |
|
2018
Q2 | $81K | Sell |
741
-375
| -34% | -$41K | 0.06% | 214 |
|
2018
Q1 | $119K | Buy |
+1,116
| New | +$119K | 0.09% | 180 |
|